Ming Liu

8PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 14, 2026
Sintilimab plus Bevacizumab biosimilar IBI305 and chemotherapy as a first-line treatment in advanced gastric or gastroesophageal junction adenocarcinoma (SBAGA): a single-arm, phase Ib/II study.

|Jul 01, 2026
Bispecific Antibody-Based Combination Therapies for B-Cell Lymphomas: Current Evidence and Future Perspectives.

|Mar 19, 2026
Danggui Buxue Decoction Attenuates H2O2-Induced HaCaT Cells by Modulating SOD2 Antioxidant and P21 Senescence Pathways.

Xingyu Chen, Huilan Zheng, Hongbin Cheng

|Jan 04, 2026
Antibody-drug conjugates in gastric cancer: clinical advances and resistance mechanisms.

Wenke Li, Mo Cheng, Hongyan Han

|Dec 23, 2025
In vivo expression of CD3/CD19 bispecific T-cell engager and α-PD-L1-Fc enables effective and durable immunotherapy for CD19+/PD-L1+ leukemia.

Yueyao Yang, Xun Liu, Jing Wei

|Jul 21, 2025
Current Advances and Future Directions for Sensitizing Gastric Cancer to Immune Checkpoint Inhibitors.

Wenke Li, Menghui Xu, Mo Cheng

Pageof 2

Frequent Collaborators

1 joint publications

Li Tu

1 joint publications

Weihan Zhang

1 joint publications

Lu Ni

1 joint publications

Zihan Xu